Top

Published in:

01-02-2012 | Breast

High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer?

Authors: K. Pinker-Domenig, W. Bogner, S. Gruber, H. Bickel, S. Duffy, M. Schernthaner, P. Dubsky, U. Pluschnig, M. Rudas, S. Trattnig, T. H. Helbich

Published in: European Radiology | Issue 2/2012

Abstract

Objective

To identify which breast lesion descriptors in the ACR BI-RADS® MRI lexicon are most strongly associated with the diagnosis of breast cancer when performing breast MR imaging at 3 T.

Methods

150 patients underwent breast MR imaging at 3 T. Lesion size, morphology and enhancement kinetics were assessed according to the BI-RADS® classification. Sensitivity, specificity and diagnostic accuracy were assessed. The effects of the BI-RADS® descriptors on sensitivity and specificity were evaluated. Data were analysed using logistic regression. Histopathological diagnoses were used as the standard of reference.

Results

The sensitivity, specificity and diagnostic accuracy of breast MRI at 3 T was 99%, 81% and 93%, respectively. In univariate analysis, the final diagnosis of malignancy was positively associated with irregular shape (p < 0.001), irregular margin (p < 0.001), heterogeneous enhancement (p < 0.001), Type 3 enhancement kinetics (p = 0.02), increasing patient age (p = 0.02) and larger lesion size (p < 0.001). In multivariate analysis, significant associations with malignancy remained for mass shape (p = 0.06), mass margin (p < 0.001), internal enhancement pattern (p = 0.03) and Type 3 enhancement kinetics (p = 0.06).

Conclusion

The ACR BI-RADS® breast lesion descriptors that are mostly strongly associated with breast cancer in breast MR imaging at 3 T are lesion shape, lesion margin, internal enhancement pattern and Type 3 enhancement kinetics.

Key Points

• 3 Tesla breast MRI allows an accurate diagnosis of breast cancer

• The BI-RADS® descriptors help provide a confident diagnosis

• The shape, margin, enhancement pattern and kinetics are the most important features

• An irregular shape and margin, heterogeneous enhancement and type-3 kinetics indicate malignancy

Helbich TH (2000) Contrast-enhanced magnetic resonance imaging of the breast. Eur J Radiol 34(3):208–219PubMedCrossRef

Kuhl C (2007) The current status of breast MR imaging - Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 244(2):356–378PubMedCrossRef

Kuhl CK (2007) Current status of breast MR imaging. Part 2. Clinical applications. Radiology 244(3):672–691PubMedCrossRef

Kinkel K, Helbich TH, Esserman LJ et al (2000) Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability. AJR Am J Roentgenol 175(1):35–43PubMed

Liberman L, Morris EA, Lee MJ et al (2002) Breast lesions detected on MR imaging: features and positive predictive value. AJR Am J Roentgenol 179(1):171–178PubMed

Vomweg TW, Teifke A, Schreiber WG, Schmidt M, Thelen M (2002) Combination of low and high resolution T1-weighted sequences for improved evaluation of morphologic criteria in dynamic contrast enhanced MRI of the breast. Rofo 174(11):1445–1449PubMedCrossRef

Pinker K, Grabner G, Bogner W et al (2009) A combined high temporal and high spatial resolution 3 Tesla MR imaging protocol for the assessment of breast lesions: initial results. Invest Radiol 44(9):553–558PubMedCrossRef

Kuhl CK, Jost P, Morakkabati N, Zivanovic O, Schild HH, Gieseke J (2006) Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience. Radiology 239(3):666–676PubMedCrossRef

Kuhl CK (2007) Breast MR imaging at 3T. Magn Reson Imaging Clin N Am 15(3):315–320, viPubMedCrossRef

10.

Noebauer-Huhmann IM, Pinker K, Barth M et al (2006) Contrast-enhanced, high-resolution, susceptibility-weighted magnetic resonance imaging of the brain: dose-dependent optimization at 3 tesla and 1.5 tesla in healthy volunteers. Invest Radiol 41(3):249–255PubMedCrossRef

11.

Pinker K, Ba-Ssalamah A, Wolfsberger S, Mlynarik V, Knosp E, Trattnig S (2005) The value of high-field MRI (3 T) in the assessment of sellar lesions. Eur J Radiol 54(3):327–334PubMedCrossRef

12.

Ba-Ssalamah A, Nobauer-Huhmann IM, Pinker K et al (2003) Effect of contrast dose and field strength in the magnetic resonance detection of brain metastases. Invest Radiol 38(7):415–422PubMed

13.

Schmitz AC, Peters NH, Veldhuis WB et al (2008) Contrast-enhanced 3.0-T breast MRI for characterization of breast lesions: increased specificity by using vascular maps. Eur Radiol 18(2):355–364PubMedCrossRef

14.

Mann RM, Kuhl CK, Kinkel K, Boetes C (2008) Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol 18(7):1307–1318PubMedCrossRef

15.

Elsamaloty H, Elzawawi MS, Mohammad S, Herial N (2009) Increasing accuracy of detection of breast cancer with 3-T MRI. AJR Am J Roentgenol 192(4):1142–1148PubMedCrossRef

16.

Radiology RVACo (2003) American College of Radiology (ACR). Breast Imaging and Reporting Data System (BI-RADS). (4th ed.)

17.

Demartini WB, Kurland BF, Gutierrez RL, Blackmore CC, Peacock S, Lehman CD (2011) Probability of malignancy for lesions detected on breast MRI: a predictive model incorporating BI-RADS imaging features and patient characteristics. Eur Radiol 21(8):1609–1617PubMedCrossRef

18.

Gutierrez RL, DeMartini WB, Eby PR, Kurland BF, Peacock S, Lehman CD (2009) BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement. AJR Am J Roentgenol 193(4):994–1000PubMedCrossRef

19.

Schnall MD, Blume J, Bluemke DA et al (2006) Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology 238(1):42–53PubMedCrossRef

20.

Collins DHC, Peters TM, Evans AC (1995) Automatic 3-D model-based neuroanatomical segmentation. Hum Brain Mapp 3(3):190–208CrossRef

21.

Morris EA (2001) Illustrated breast MR lexicon. Semin Roentgenol 36(3):238–249PubMedCrossRef

22.

Morris EA (2001) Review of breast MRI: indications and limitations. Semin Roentgenol 36(3):226–237PubMedCrossRef

23.

Kuhl CK, Mielcareck P, Klaschik S et al (1999) Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 211(1):101–110PubMed

24.

Nunes LW, Schnall MD, Orel SG (2001) Update of breast MR imaging architectural interpretation model. Radiology 219(2):484–494PubMed

25.

Nunes LW, Schnall MD, Orel SG et al (1997) Breast MR imaging: interpretation model. Radiology 202(3):833–841PubMed

26.

Kuhl CK, Schild HH, Morakkabati N (2005) Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution. Radiology 236(3):789–800PubMedCrossRef

27.

Agrawal G, Su MY, Nalcioglu O, Feig SA, Chen JH (2009) Significance of breast lesion descriptors in the ACR BI-RADS MRI lexicon. Cancer 115(7):1363–1380PubMedCrossRef

28.

Tardivon AA, Athanasiou A, Thibault F, El Khoury C (2007) Breast imaging and reporting data system (BI-RADS): magnetic resonance imaging. Eur J Radiol 61(2):212–215PubMedCrossRef

29.

Floery D, Helbich TH (2006) MRI-Guided percutaneous biopsy of breast lesions: materials, techniques, success rates, and management in patients with suspected radiologic-pathologic mismatch. Magn Reson Imaging Clin N Am 14(3):411–425, viiiPubMedCrossRef

30.

Schueller G, Jaromi S, Ponhold L et al (2008) US-guided 14-gauge core-needle breast biopsy: results of a validation study in 1352 cases. Radiology 248(2):406–413PubMedCrossRef

31.

Kluttig A, Trocchi P, Heinig A et al (2007) Reliability and validity of needle biopsy evaluation of breast-abnormalities using the B-categorization–design and objectives of the Diagnosis Optimisation Study (DIOS). BMC Cancer 7:100PubMedCrossRef

32.

Pathologists RCo (2001) NHS Cancer Screening Programes: Guidelinesfor non-operative diagnostic procedures and reporting in breast cancer screening(ed)^(eds). NSHBSP publication, Sheffield

33.

Pathology EWGoBS (2006) Quality assurance guidelines for pathologyEuropean guidelines for quality assurance in cancer screening and diagnosis, 4th edn. European Union, pp 219–312

34.

Gutierrez RL, Demartini WB, Eby P, Kurland BF, Peacock S, Lehman CD (2009) Clinical indication and patient age predict likelihood of malignancy in suspicious breast MRI lesions. Acad Radiol 16(10):1281–1285PubMedCrossRef

35.

Baltzer PA, Benndorf M, Dietzel M, Gajda M, Runnebaum IB, Kaiser WA (2010) False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study. AJR Am J Roentgenol 194(6):1658–1663PubMedCrossRef

36.

Liberman L, Mason G, Morris EA, Dershaw DD (2006) Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size. AJR Am J Roentgenol 186(2):426–430PubMedCrossRef

37.

Wang LC, DeMartini WB, Partridge SC, Peacock S, Lehman CD (2009) MRI-detected suspicious breast lesions: predictive values of kinetic features measured by computer-aided evaluation. AJR Am J Roentgenol 193(3):826–831PubMedCrossRef

38.

Boetes C, Veltman J, van Die L, Bult P, Wobbes T, Barentsz JO (2004) The role of MRI in invasive lobular carcinoma. Breast Cancer Res Treat 86(1):31–37PubMedCrossRef

39.

Kuhl CK (2009) Why do purely intraductal cancers enhance on breast MR images? Radiology 253(2):281–283PubMedCrossRef

40.

Goto M, Ito H, Akazawa K et al (2007) Diagnosis of breast tumors by contrast-enhanced MR imaging: comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features. J Magn Reson Imaging 25(1):104–112PubMedCrossRef

41.

Pinker K, Stadlbauer A, Bogner W, Gruber S, Helbich TH (2010) Molecular imaging of cancer: MR spectroscopy and beyond. Eur J Radiol

42.

Bogner WPK, Gruber S, Grabner G, Stadlbauer A, Weber M, Moser E, Helbich TH, Trattnig S (2009) Diffusion-weighted MRI for differentiation of breast lesions at 3.0 Tesla: How does selection of diffusion schemes affect diagnosis? Radiology 253(2):341–351PubMedCrossRef

43.

Pinker K, Brader P, Karanikas G et al (2010) Functional and molecular imaging of breast tumors. Radiologe 50(11):1030–1038PubMedCrossRef

44.

Gruber S., Debski B, Pinker K, et al. Three dimensional proton magnetic resonance spectroscopic imaging (3D-MRSI) for differentiation of benign and malignant breast lesions at 3 Tesla. Radiology

45.

Kuhl CK, Schrading S, Bieling HB et al (2007) MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 370(9586):485–492PubMedCrossRef

46.

Diekmann F, Diekmann S, Beljavskaja M et al (2004) Preoperative MRT of the breast in invasive lobular carcinoma in comparison with invasive ductal carcinoma. Rofo 176(4):544–549PubMedCrossRef

47.

Dietzel M, Baltzer PA, Vag T et al (2010) Magnetic resonance mammography of invasive lobular versus ductal carcinoma: systematic comparison of 811 patients reveals high diagnostic accuracy irrespective of typing. J Comput Assist Tomogr 34(4):587–595PubMedCrossRef

Title: High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer?
Authors: K. Pinker-Domenig
W. Bogner
S. Gruber
H. Bickel
S. Duffy
M. Schernthaner
P. Dubsky
U. Pluschnig
M. Rudas
S. Trattnig
T. H. Helbich
Publication date: 01-02-2012
Publisher: Springer-Verlag
Published in: European Radiology / Issue 2/2012
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-011-2256-6

At a glance: The STEP trials

Springer Medicine

High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer?

Abstract

Objective

Methods

Results

Conclusion

Key Points

At a glance: The STEP trials

Springer Medicine

Abstract

Objective

Methods

Results

Conclusion

Key Points

Please log in to get access to this content

Other articles of this Issue 2/2012

Evaluation of a robotic technique for transrectal MRI-guided prostate biopsies

Recent literature

MRI contrast enhancement of malignant liver tumours following successful cryoablation

Discrimination of paediatric brain tumours using apparent diffusion coefficient histograms

MRI-based motion correction of thoracic PET: initial comparison of acquisition protocols and correction strategies suitable for simultaneous PET/MRI systems

Volumetric feedback ablation of uterine fibroids using magnetic resonance-guided high intensity focused ultrasound therapy